Physician
Rheumatology
Dr. David G. Borenstein, MD
David Borenstein is an expert in the field of Rheumatology. He researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine has a rank of 3 in research and a 29 in primary care He received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACR)". David G. Borenstein, MD is a published physician. He published 45 publications, including: 'Management of neck pain: a primary care approach.' David Borenstein accepts all Medicare patients.
Publications
- Mechanical low back Pain-a rheumatologist's view.
- ACR presidential address advancing rheumatology: Mission possible.
- Efficacy and safety of tanezumab in the treatment of Chronic low back pain.
- The role of the rheumatologist in managing Pain therapy.
- Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid Arthritis failing previous disease-modifying antirheumatic therapy: the...
- Cyclobenzaprine ER for muscle spasm associated with low back and Neck pain: two randomized, double-blind, placebo-controlled studies of identical design.
- Chronic neck pain: how to approach treatment.
- Chronic low back pain in a working-age adult.
- Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute Neck or back pain with muscle spasm: a randomized trial.
- Opioids: to use or not to use? That is the question.
- Does osteoArthritis of the lumbar spine cause chronic low back pain?
- Effects of valdecoxib in the treatment of Chronic low back pain: results of a randomized, placebo-controlled trial.
- Efficacy and safety of rofecoxib in patients with Chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
- Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: results of two placebo-controlled trials.
- A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid Arthritis.
- Beginning the treatment of musculoskeletal Pain.
- The value of magnetic resonance imaging of the lumbar spine to predict low-back Pain in asymptomatic subjects : a seven-year follow-up study.
- Celecoxib versus diclofenac in the management of osteoArthritis of the knee.
- Epidemiology, etiology, diagnostic evaluation, and treatment of low back Pain.
- Management of Neck pain: a primary care approach.
- How to recognize and treat specific low back Pain?
- A clinician's approach to acute low back Pain.
- Chronic low back pain.
- Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation.
- Prevalence and treatment outcome of primary and secondary fibromyalgia in patients with spinal Pain.
- Siliconosis: a spectrum of illness.
- Epidemiology, etiology, diagnostic evaluation, and therapy of low back Pain.
- Exercise for the low back Pain patient.
- Approach to initial medical treatment of rheumatoid Arthritis.
- Lumbar spine Disease in the elderly.
- Medical therapy of low back Pain.
- The American College of Rheumatology criteria for the classification and reporting of osteoArthritis of the hip.
- The current approach to the medical diagnosis of low back Pain.
- Low back Pain: epidemiology, etiology, diagnostic evaluation, and therapy.
- The American College of Rheumatology criteria for the classification and reporting of osteoArthritis of the hand.
- Evaluation of cervical spine inflammatory Arthritis with somatosensory evoked potentials.
- Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back Pain and muscle spasm.
- Reflex sympathetic dystrophy localized to a single digit.
- Multiple autoimmune Diseases in a predisposed patient.
- Evaluation and outcome of low-back Pain of unknown etiology.
- Successful joint arthroplasty following Proteus morganii (Morganella morganii) septic Arthritis: a four-year study.
- Development of criteria for the classification and reporting of osteoArthritis. Classification of osteoArthritis of the knee. Diagnostic and Therapeutic Criteria Commi...
- Gas-liquid chromatographic analysis of synovial fluid. Succinic acid and lactic acid as markers for septic Arthritis.
- The absence of back pain in classical Ankylosing spondylitis.
Schools
Johns Hopkins University School Of Medicine
Johns Hopkins Hospital
Procedures Preformed
- Biological Therapy
- Bone Density Scan
- Injection Therapy
- Joint Drainage
- View All
Conditions Treated
- Achilles Tendinitis
- Adhesive Capsulitis
- Ankylosing Vertebral Hyperostosis
- Arthritis
- View All
Doctors Specialties
Accepted Insurances
- Choice Plus POS II
- Select
- Bakery & Confectionary Union Plan
- Blue Card PPO
- Blue Choice Advantage
- Blue Choice Network POS
- Blue Preferred PPO
- CareFirst Maryland POS
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- CoreSource
- Southern Health PPO
- First Health (Coventry Health Care) PPO
- GEHA
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACR)
Education
-
Johns Hopkins University
-
Johns Hopkins University School of Medicine
Drug Facts
| NPI NUMBER |
|
1366441727 |
| NPPES Provider LastName |
|
BORENSTEIN |
| NPPES Provider FirstName |
|
DAVID |
| NPPES Provider ZIPCode |
|
200061003 |
| NPPES Provider State |
|
DC |
| Specialty Description |
|
Rheumatology |
| Total Claim Count |
|
1137.0 |
| Distinct Opioid Count |
|
8.0 |
| Opioid Claim Count |
|
219.0 |
| Percent Opioid Claims |
|
19.26 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1366441727 |
| Last Name Of The Provider |
BORENSTEIN |
| First Name Of The Provider |
DAVID |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
